<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) gene are found in more than 80% of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>The nuclear transcription factor Nrf2 plays a central role in the regulation of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Previously, we have shown that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> in Nrf2(-/-) (Nrf2 knockout; KO) mice resulted in higher expression of inflammatory markers and cytokines, coupled with higher inflammatory damage to the colonic crypt cells, as compared to the Nrf2(+/+) (<z:mp ids='MP_0002169'>wild type</z:mp>; WT) mice </plain></SENT>
<SENT sid="3" pm="."><plain>Induction of mutation in the colon by administration of carcinogen, AOM prior to DSS-induced <z:mp ids='MP_0001845'>inflammation</z:mp> resulted in higher <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence and numbers in Nrf2KO mice </plain></SENT>
<SENT sid="4" pm="."><plain>These results indicate that Nrf2-dependent inhibition of <z:mp ids='MP_0001845'>inflammation</z:mp> appears to be critical in inhibiting mutation-initiated colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, we aim to investigate if loss of Nrf2 would dose-dependently promote intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in Apc(min/+) mice </plain></SENT>
<SENT sid="6" pm="."><plain>To demonstrate the in vivo mechanisms, we constructed both Apc mutated and Nrf2 deficient strain Apc(min/+) mice with C57BL/6 Nrf2KO mice to obtain F1, Apc(min/+) ;Nrf2(+/-) and F2, Apc(min/+) ;Nrf2(-/-) mice </plain></SENT>
<SENT sid="7" pm="."><plain>Nrf2KO decreased the protein expression of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme NQO1 in Apc(min/+)  </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, Nrf2KO enhanced the expression of inflammatory markers such as COX-2, cPLA, LTB(4) in Apc(min/+)  </plain></SENT>
<SENT sid="9" pm="."><plain>Finally, Nrf2KO resulted in higher level of PCNA and c-Myc expression in intestinal tissue, indicating the deficiency of Nrf2 promotes proliferation of intestinal crypt cells in Apc(min/+)  </plain></SENT>
<SENT sid="10" pm="."><plain>Taken together, our results suggest that Nrf2KO attenuates anti-<z:mp ids='MP_0003674'>oxidative stress</z:mp> pathway, induces <z:mp ids='MP_0001845'>inflammation</z:mp>, and increases proliferative potential in the intestinal crypts leading to enhanced intestinal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:mpath ids='MPATH_270'>adenomas</z:mpath> in Apc(min/+) . Â© 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>